I had the opportunity to witness an MoU signing between @ClinicalRsrchMY @KKMPutrajaya and @DNDi to develop safe, affordable, effective and accessible treatments for dengue fever within five years. pic.twitter.com/IlWAF0sCHY
Replying to @Khairykj
. @DNDi and @ClinicalRsrchMY will work together with @ICR_NIH dan IMR to progress preclinical investigations of potential treatments, test the efficacy of repurposed drug candidates and implement clinical trials of the most promising ones.

Engagement Map



No retweeters found
9 retweeters not shown
Free access is provided to the 8 hour timeframe for this page.

A Trendsmap Explore subscription provides full access to all available timeframes

Find out more

This account is already logged in to Trendsmap.
Your subscription allows access for one user. If you require access for more users, you can create additional subscriptions.
Please Contact us if you are interested in discussing discounts for 3+ users for your organisation, or have any other queries.